[Long acting insulin analogs: possibly more stable glucose regulation].
Huvers
F
F
Universitair Medisch Centrum St Radboud, afd. Algemene Interne Geneeskunde, AIG 541, Postbus 9101, 6500 HB Nijmegen. f.huvers@aig.umcn.nl
D001786:Blood Glucose / Q000187:drug effects / Q000378:metabolism*; D003692:Delayed-Action Preparations; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D006442:Glycated Hemoglobin / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D007003:Hypoglycemia / Q000097:blood / Q000517:prevention & control; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007328:Insulin / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D000069036:Insulin Glargine; D007336:Insulin, Isophane / Q000627:therapeutic use; D049528:Insulin, Long-Acting
D001786:Blood Glucose; D003692:Delayed-Action Preparations; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D007328:Insulin; D000069036:Insulin Glargine; D007336:Insulin, Isophane; D049528:Insulin, Long-Acting
Langwerkende insulineanaloga: mogelijk stabielere glucoseregulatie.